{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:12:00Z","timestamp":1772640720773,"version":"3.50.1"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"SOCIETE FRANCAISE DE RHUMATOLOGIE","award":["MASTER DEGREE"],"award-info":[{"award-number":["MASTER DEGREE"]}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Fibrous dysplasia (FD) is a rare bone disease caused by activating mutations of GNAS encoding the Gs\u03b1 protein, enhancing cyclic adenosine monophosphate (cAMP) production by overstimulation of adenylyl cyclase and impairing osteoblastic differentiation. The clinical presentation ranges from asymptomatic to polyostotic forms with severe disability, explained by the mosaic distribution of the GNAS mutation. Physicians have to deal with the gap of knowledge in FD pathogenesis, the absence of prognostic markers and the lack of specific treatment. The identification of specific biomarkers for FD is an important step to improve the clinical and therapeutic approaches. An epigenetic regulation driven by microRNAs (miRNAs), known as promising biomarkers in bone disease, could be involved in FD. We have sought circulating miRNAs that are differentially expressed in FD patients compared to controls and would reflect dysregulations of osteogenesis-related genes and bone disorder. The global miRNA profiling was performed using Next Generation Sequencing in patient serum collected from a discovery cohort of 20 patients (10 polyostotic and 10 monostotic) and 10 controls. From these, we selected 19 miRNAs for a miRNA validation phase from serum of 82 patients and 82 controls, using real-time qPCR. Discovery screening identified 111 miRNAs differentially expressed in patient serum, after adjusting for the false discovery rate (FDR). Among the 82 patients, 55% were polyostotic, and 73% were women with a mean age of 42\u2009years. Six miRNAs (miR-25-3p, miR-93-5p, miR-182-5p, miR-324-5p, miR-363-3p, and miR-451a) were significantly overexpressed in serum, with FDR &amp;lt;0.05. The expression level of these six miRNAs was not associated with the FD severity. In conclusion, we identified a signature of circulating miRNAs associated with FD. These miRNAs are potential negative regulators of gene expression in bone cell progenitors, suggesting their activity in FD by interfering with osteoblastic and osteoclastic differentiation to impair bone mineralization and remodeling processes. \u00a9 2020 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.4111","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T12:37:34Z","timestamp":1591879054000},"page":"1881-1892","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A Signature of Circulating miRNAs Associated With Fibrous Dysplasia of Bone: the mirDys Study"],"prefix":"10.1093","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-3368","authenticated-orcid":false,"given":"M\u00e9lanie A","family":"Legrand","sequence":"first","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"},{"name":"Department of Rheumatology Edouard Herriot University Hospital Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Millet","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Merle","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Rousseau","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anaelle","family":"Hemmendinger","sequence":"additional","affiliation":[{"name":"The Lymphoma Academic Research Organization (LYSARC) Pierre-B\u00e9nite France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Gineyts","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2573-5316","authenticated-orcid":false,"given":"Elisabeth","family":"Sornay-Rendu","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4168-6697","authenticated-orcid":false,"given":"Pawel","family":"Szulc","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Borel","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Croset","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-6385","authenticated-orcid":false,"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[{"name":"INSERM UMR 1033 Universit\u00e9 de Lyon Lyon France"},{"name":"Department of Rheumatology Edouard Herriot University Hospital Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/berh.1999.0071","article-title":"Fibrous dysplasia of bone","volume":"14","author":"Chapurlat","year":"2000","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"issue":"Suppl 2","key":"2024031419514369500_jbmr4111-bib-0002","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1359\/jbmr.06s223","article-title":"G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome","volume":"21","author":"Weinstein","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1\u200a S activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr Rev"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0004","first-page":"489","article-title":"Cellular and molecular biology of fibrous dysplasia","volume":"21","author":"Marie","year":"2001","journal-title":"Ann Pathol"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI118773","article-title":"Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome","volume":"98","author":"Yamamoto","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jbmr.3602","article-title":"Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden","volume":"34","author":"de Castro","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024031419514369500_jbmr4111-bib-0007","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/jbmr.2894","article-title":"Prognostic factors from an epidemiologic evaluation of fibrous dysplasia of bone in a modern cohort: the FRANCEDYS study","volume":"31","author":"Benhamou","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1359\/JBMR.041111","article-title":"An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2024031419514369500_jbmr4111-bib-0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2019.01.004","article-title":"Serum periostin levels and severity of fibrous dysplasia of bone","volume":"121","author":"Guerin Lemaire","year":"2019","journal-title":"Bone"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"23","key":"2024031419514369500_jbmr4111-bib-0011","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1073\/pnas.0703820104","article-title":"Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5\u2032 UTR as in the 3\u2032 UTR","volume":"104","author":"Lytle","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2024031419514369500_jbmr4111-bib-0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"3","key":"2024031419514369500_jbmr4111-bib-0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1253","article-title":"Dicer is essential for mouse development","volume":"35","author":"Bernstein","year":"2003","journal-title":"Nat Genet"},{"issue":"7","key":"2024031419514369500_jbmr4111-bib-0014","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1074\/jbc.M805777200","article-title":"Impaired micro-RNA pathways diminish osteoclast differentiation and function","volume":"284","author":"Sugatani","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ydbio.2010.01.008","article-title":"Dicer inactivation in osteoprogenitor cells compromises fetal survival and bone formation, while excision in differentiated osteoblasts increases bone mass in the adult mouse","volume":"340","author":"Gaur","year":"2010","journal-title":"Dev Biol"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0016","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcb.22228","article-title":"Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption","volume":"109","author":"Mizoguchi","year":"2010","journal-title":"J Cell Biochem"},{"issue":"4","key":"2024031419514369500_jbmr4111-bib-0017","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-016-3847-5","article-title":"MicroRNAs in bone diseases","volume":"28","author":"Gennari","year":"2017","journal-title":"Osteoporos Int"},{"key":"2024031419514369500_jbmr4111-bib-0018","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bonekey.2015.56","article-title":"Tumour-derived miRNAs and bone metastasis","volume":"4","author":"Croset","year":"2015","journal-title":"Bonekey Rep"},{"key":"2024031419514369500_jbmr4111-bib-0019","article-title":"Non-coding RNAs in bone Remodelling and bone metastasis: mechanisms of action and translational relevance","author":"Puppo","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2024031419514369500_jbmr4111-bib-0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11914-019-00510-4","article-title":"MicroRNAs in bone metastasis","volume":"17","author":"Hesse","year":"2019","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"2024031419514369500_jbmr4111-bib-0021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/ijms17030349","article-title":"MicroRNAs in osteoclastogenesis and function: potential therapeutic targets for osteoporosis","volume":"17","author":"Ji","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/03008207.2016.1139580","article-title":"MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis","volume":"58","author":"Suttamanatwong","year":"2017","journal-title":"Connect Tissue Res"},{"issue":"8","key":"2024031419514369500_jbmr4111-bib-0023","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/jbmr.2175","article-title":"Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures","volume":"29","author":"Seeliger","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0024","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/jbmr.3685","article-title":"Lack of association between select circulating miRNAs and bone mass, turnover, and fractures: data from the OFELY cohort","volume":"34","author":"Feurer","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.berh.2007.11.004","article-title":"Fibrous dysplasia of bone and McCune-Albright syndrome","volume":"22","author":"Chapurlat","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0026","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2024031419514369500_jbmr4111-bib-0027","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.1997.12.4.683","article-title":"Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort","volume":"12","author":"Arlot","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024031419514369500_jbmr4111-bib-0028","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.061206","article-title":"Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study","volume":"22","author":"Sornay-Rendu","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0029","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00198-012-2223-3","article-title":"Impaired trabecular and cortical microarchitecture in daughters of women with osteoporotic fracture: the MODAM study","volume":"24","author":"Nagy","year":"2013","journal-title":"Osteoporos Int"},{"issue":"11","key":"2024031419514369500_jbmr4111-bib-0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/jbmr.124","article-title":"Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study","volume":"25","author":"Chaitou","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0031","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1261\/rna.030916.111","article-title":"Evaluation of normalization methods in mammalian microRNA-Seq data","volume":"18","author":"Garmire","year":"2012","journal-title":"RNA"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0032","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1373\/clinchem.2013.206375","article-title":"The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments","volume":"59","author":"Huggett","year":"2013","journal-title":"Clin Chem"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0033","doi-asserted-by":"crossref","first-page":"e0216947","DOI":"10.1371\/journal.pone.0216947","article-title":"Selected serum microRNA, abdominal aortic calcification and risk of osteoporotic fracture","volume":"14","author":"Pickering","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"8903","key":"2024031419514369500_jbmr4111-bib-0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"343","author":"Liens","year":"1994","journal-title":"Lancet"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0036","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2004.03.004","article-title":"Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment","volume":"35","author":"Chapurlat","year":"2004","journal-title":"Bone"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0037","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jbmr.2999","article-title":"Outcome of long-term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia","volume":"32","author":"Majoor","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024031419514369500_jbmr4111-bib-0038","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbmr.1603","article-title":"Denosumab treatment for fibrous dysplasia","volume":"27","author":"Boyce","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2024031419514369500_jbmr4111-bib-0039","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/jbmr.1604","article-title":"miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1","volume":"27","author":"Kim","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0040","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1038\/s41467-018-06446-0","article-title":"Bone protection by inhibition of microRNA-182","volume":"9","author":"Inoue","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"2024031419514369500_jbmr4111-bib-0041","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cmet.2010.01.001","article-title":"FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts","volume":"11","author":"Rached","year":"2010","journal-title":"Cell Metab"},{"issue":"12","key":"2024031419514369500_jbmr4111-bib-0042","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1502044","article-title":"RBP-J-regulated miR-182 promotes TNF-\u03b1-induced osteoclastogenesis","volume":"196","author":"Miller","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0043","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yexcr.2016.07.010","article-title":"miR-106b-5p and miR-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation","volume":"347","author":"Fang","year":"2016","journal-title":"Exp Cell Res"},{"key":"2024031419514369500_jbmr4111-bib-0044","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bone.2017.01.014","article-title":"Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2","volume":"97","author":"Liu","year":"2017","journal-title":"Bone"},{"key":"2024031419514369500_jbmr4111-bib-0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.biopha.2018.01.103","article-title":"MiR-25 promotes proliferation, differentiation and migration of osteoblasts by up-regulating Rac1 expression","volume":"99","author":"Li","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2024031419514369500_jbmr4111-bib-0046","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2019.11.043","article-title":"MicroRNA-25-3p regulates osteoclasts through nuclear factor I X","volume":"522","author":"Huang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2024031419514369500_jbmr4111-bib-0047","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/jbmr.1621","article-title":"miR-93\/Sp7 function loop mediates osteoblast mineralization","volume":"27","author":"Yang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2024031419514369500_jbmr4111-bib-0048","doi-asserted-by":"crossref","first-page":"e0182678","DOI":"10.1371\/journal.pone.0182678","article-title":"Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"issue":"14","key":"2024031419514369500_jbmr4111-bib-0049","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1038\/sj.emboj.7600282","article-title":"The Fos-related antigen Fra-1 is an activator of bone matrix formation","volume":"23","author":"Eferl","year":"2004","journal-title":"EMBO J"},{"issue":"20","key":"2024031419514369500_jbmr4111-bib-0050","doi-asserted-by":"crossref","first-page":"33375","DOI":"10.18632\/oncotarget.16498","article-title":"Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma","volume":"8","author":"Fujiwara","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0051","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","article-title":"Malignancies in fibrous dysplasia","volume":"73","author":"Ruggieri","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0052","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11626-019-00344-5","article-title":"miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN\/PI3K\/AKT signaling pathway","volume":"55","author":"Li","year":"2019","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2024031419514369500_jbmr4111-bib-0053","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.matbio.2018.08.009","article-title":"miR-324-5p is up regulated in end-stage osteoarthritis and regulates Indian Hedgehog signalling by differing mechanisms in human and mouse","volume":"77","author":"Woods","year":"2019","journal-title":"Matrix Biol"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0054","first-page":"2940","article-title":"Identification of differentially expressed microRNAs in the bone marrow of osteoporosis patients","volume":"11","author":"Gu","year":"2019","journal-title":"Am J Transl Res"},{"key":"2024031419514369500_jbmr4111-bib-0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bone.2018.09.007","article-title":"Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation","volume":"117","author":"Karvande","year":"2018","journal-title":"Bone"},{"issue":"5","key":"2024031419514369500_jbmr4111-bib-0056","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-016-0317-0","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: clinical and translational perspectives","volume":"14","author":"Robinson","year":"2016","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"2024031419514369500_jbmr4111-bib-0057","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1359\/jbmr.080609","article-title":"Age-dependent demise of GNAS-mutated skeletal stem cells and \u201cnormalization\u201d of fibrous dysplasia of bone","volume":"23","author":"Kuznetsov","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024031419514369500_jbmr4111-bib-0058","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1359\/jbmr.070511","article-title":"Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome","volume":"22","author":"Hart","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024031419514369500_jbmr4111-bib-0059","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1677\/JME-10-0097","article-title":"Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells","volume":"45","author":"Riminucci","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"2024031419514369500_jbmr4111-bib-0060","doi-asserted-by":"crossref","first-page":"115104","DOI":"10.1016\/j.bone.2019.115104","article-title":"MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis","volume":"131","author":"Kocijan","year":"2019","journal-title":"Bone"},{"key":"2024031419514369500_jbmr4111-bib-0061","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases - complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol Cell Endocrinol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.4111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/35\/10\/1881\/56974662\/jbmr4111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/35\/10\/1881\/56974662\/jbmr4111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T15:59:00Z","timestamp":1710431940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/35\/10\/1881\/7516778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,11]]},"references-count":61,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,6,11]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4111","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4111\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4111\/v2\/decision1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,6,11]]},"assertion":[{"value":"2020-02-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}